Mukai H - Search Results

1

Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag.

Kaufmann P, Okubo K, Bruderer S, Mant T, Yamada T, Dingemanse J, Mukai H. Kaufmann P, et al. Among authors: mukai h. Am J Cardiovasc Drugs. 2015 Jun;15(3):195-203. doi: 10.1007/s40256-015-0117-4. Am J Cardiovasc Drugs. 2015. PMID: 25850750 Free PMC article. Clinical Trial.

2

Investigation of Potential Pharmacodynamic and Pharmacokinetic Interactions Between Selexipag and Warfarin in Healthy Male Subjects.

Bruderer S, Okubo K, Mukai H, Mant T, Dingemanse J. Bruderer S, et al. Among authors: mukai h. Clin Ther. 2016 May;38(5):1228-1236.e1. doi: 10.1016/j.clinthera.2016.03.014. Epub 2016 Apr 8. Clin Ther. 2016. PMID: 27063071 Clinical Trial.

3

In vitro melanin binding of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist.

Yamada T, Okuyama Y, Mukai H. Yamada T, et al. Among authors: mukai h. Arzneimittelforschung. 2001;51(4):299-303. doi: 10.1055/s-0031-1300041. Arzneimittelforschung. 2001. PMID: 11367870

4

Effects of irsogladine on P450-isoform specific activities in human hepatic microsomes.

Nakamura A, Tougou K, Kitazumi H, Yamada T, Honjou K, Nonaka K, Mukai H. Nakamura A, et al. Among authors: mukai h. Arzneimittelforschung. 2006;56(7):547-52. doi: 10.1055/s-0031-1296750. Arzneimittelforschung. 2006. PMID: 16927538

5

Effects of etodolac on P450 isoform-specific activities in human hepatic microsomes.

Nakamura A, Tougou K, Kitazumi H, Yamada T, Honjou K, Zinno A, Nonaka K, Mukai H. Nakamura A, et al. Among authors: mukai h. Arzneimittelforschung. 2005;55(12):744-8. doi: 10.1055/s-0031-1296924. Arzneimittelforschung. 2005. PMID: 16430028

6

Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.

Mukai H, Watanabe S, Morino A. Mukai H, et al. Arzneimittelforschung. 1999 May;49(5):434-40. doi: 10.1055/s-0031-1300439. Arzneimittelforschung. 1999. PMID: 10367106

7

Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 2nd communication: Absorption and excretion in rabbits, dogs and monkeys after a single administration of 14C-NS-49.

Mukai H, Watanabe S, Morino A. Mukai H, et al. Arzneimittelforschung. 1999 Jun;49(6):527-32. doi: 10.1055/s-0031-1300455. Arzneimittelforschung. 1999. PMID: 10417870

8

Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 3rd communication: metabolism in rats, rabbits, dogs and monkeys, and effects on hepatic drug-metabolizing enzyme activities in rats after repeated administration.

Mukai H, Watanabe S, Morino A. Mukai H, et al. Arzneimittelforschung. 1999 Jul;49(7):612-7. doi: 10.1055/s-0031-1300471. Arzneimittelforschung. 1999. PMID: 10442210

9

Tissue distribution of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist, in pigmented rats.

Koike T, Kitazumi H, Mukai H. Koike T, et al. Among authors: mukai h. Arzneimittelforschung. 2001;51(5):402-7. doi: 10.1055/s-0031-1300054. Arzneimittelforschung. 2001. PMID: 11413741

10

Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 4th communication: tissue distribution, placental transfer and milk secretion of radioactivity in rats after a single oral administration of 14C-NS-49, and effects of repeated administration on its pharmacokinetics.

Dalrymple PD, Beeby TL, Mukai H, Chasseaud LF. Dalrymple PD, et al. Among authors: mukai h. Arzneimittelforschung. 2001;51(5):394-401. doi: 10.1055/s-0031-1300053. Arzneimittelforschung. 2001. PMID: 11413740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

844 results

Search Page

Filters